Symbol
| SIX1
| contributors: mct/npt/pgu - updated : 22-01-2014
|
HGNC name
| SIX homeobox 1
|
HGNC id
| 10887
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in metastatic rhabdomyosarcoma | constitutional
|  
|  
| --over
|  
|
can attenuate a DNA damage-induced G(2) cell cycle checkpoint | tumoral
|  
|  
| --low
|  
|
in 44 p100 of primary breast cancers and 90 p100 of metastatic lesions | tumoral
|  
|  
| --over
|  
|
in osteosarcoma cell lines compared to human osteoblastic cell line | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | bone | | |
inhibition of SIX1 promotes apoptosis, suppresses proliferation, and migration of osteosarcoma cells |
| | | |
| Six1-deficient mice lack kidneys, but form ureters | |
Six1(-/-) embryos and newborn mice exhibit mesenchymal overproliferation, decreased Fgf10 expression and severe defects in the smooth muscle component of the bronchi and major pulmonary vessels |